The Hematology Division is a multifaceted division supporting multiple clinical programs including oncology, transplant, neuroscience and cardiovascular – providing a comprehensive menu of basic and advanced hematology tests and consultative services.
The Flow Cytometry Division offers state of the art diagnostic services and has set the world wide standard for CD34 (stem cell) enumeration for bone marrow transplantation and paroxysmal nocturnal hemoglobinuria (PNH) testing.
Other testing services in hematology and flow cytometry include routine testing, highly specialized coagulation testing, hemoglobinopathy and immunophenotyping of leukocyte subsets and hematologic malignancies. Consultation services include providing diagnostic advice on complex cases, routine interpretation of tests, collaborative diagnosis, and scientific, strategic, and regulatory consultations.
The Hematology and Flow Cytometry labs work closely with other lab medicine departments such as molecular diagnostics and cytogenetics to deliver comprehensive, clinical diagnoses for a range of disorders.
Tests and Consultations
Routine and Special Hematology
- Complete Blood Count (CBC) and Blood Film Review
- Reticulocyte count
- Erythrocyte Sedimentation Rate (ESR)
- Body Fluid Cell Counts and morphology review
- Malaria and smear review for blood parasites
- Sickle Cell Screening
- Urine Hemosiderin
- Hemoglobinopathy studies (Sickle Cell Screen, Capillary Electrophoresis, Alkaline Gel Electrophoresis, Hemoglobin H Testing)
- Bone marrow imprint and aspirate staining
- Iron staining
Routine and Special Coagulation
- Coagulation profiles, screening for factors and inhibitors
- Heparin therapy monitoring
- Dabigatran and Argatroban therapy monitoring
- Platelet studies
- Thrombophilia testing
Hematopathology
- Blood film consultations and interpretive report
- Bone marrow consultations and interpretive report
Flow Cytometry
- CD 34 (stem cell) enumeration
- CD4/CD8 monitoring
- Leukemia/lymphoma immunophenotyping
- Paroxysmal Nocturnal Hemoglobinuria (PMH) assay
- Measurable Residual Disease, Acute Lymphoblastic Leukemia (ALL) including B-ALL and T-ALL
- Measurable Residual Disease, Acute Myeloid Leukemia (AML)
- Measurable Residual Disease, Chronic Lymphocytic Leukemia (CLL)
- Measurable Residual Disease, Multiple Myeloma (MM)
Contacts
Coagulation
- Dr. Rita Selby, Hematologist, Medical Director
